Test Price
1,800 AED✅ Home Collection Available
Growth Disorder Comprehensive Panel in UAE | 1800 AED
Executive Summary & Core Metrics
Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM - 11 PM).
Clinical Guidance
Telephonic Post-Test Clinical Guidance for result interpretation with our specialist coordinators.
Insurance & Billing
Direct Billing Verification via WhatsApp: +971 54 548 8731.
The Growth Disorder Comprehensive Panel is a critical diagnostic tool for evaluating the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) axis. Performed using high-sensitivity chemiluminescent immunoassay (CLIA) technology, this panel assists in differentiating growth hormone deficiency from constitutional delay and other endocrine disorders. Results are reported same-day to facilitate timely clinical decisions.
Test Overview & Methodology
This panel quantitatively measures Insulin-like Growth Factor-1 (IGF-1) and Growth Hormone (GH) using a robust Chemiluminescent Immunoassay (CLIA) methodology. It serves as a first-line diagnostic tool for evaluating growth disorders, strictly adhering to the latest UAE reference intervals and quality standards.
| Feature | Our: Growth Disorder Panel | Closest Alternative: Standard GH Assay |
|---|---|---|
| Precision | Ultra-sensitive Chemiluminescent Immunoassay (CV < 3%) | Conventional ELISA; higher inter-assay variability |
| Methodology | Quantitative, ISO 9001:2015 Standardized | Semi-Quantitative, non-ISO standardized |
| Turnaround Time | Same-Day Reporting (Sample Mon/Thu by 4 pm) | 3-5 Working Days |
Physician Insight & Safety Protocols
"Interpreting growth disorder panels requires a holistic view of the patient's clinical history and growth velocity. Always correlate laboratory findings with bone age radiography and nutritional status before initiating therapy; a single abnormal value does not confirm pathology."
— Dr. Ajay Singh, DHA Registration ID: 36234132, General Practitioner.
Critical Medication Warning
Do not discontinue prescribed medications, particularly corticosteroids, thyroid hormones, or recombinant human growth hormone, without direct consultation and approval from your supervising physician. Abrupt cessation can precipitate an adrenal crisis or severe metabolic decompensation.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Non-fasting state (< 8 hours) invalidates baseline GH; hemolyzed or thawed specimens are rejected.
- ER Red Flag: If patient reports sudden severe headache, visual field loss, or acute joint pain suggestive of slipped capital femoral epiphysis, advise immediate emergency evaluation.
- Pediatric Safety: Parental consent is mandatory for all venipunctures under 18 years, in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. Why is overnight fasting mandatory for this growth disorder panel, and can I drink water?
Fasting for 8-12 hours is strictly required to establish a basal, unstimulated Growth Hormone level, as recent food intake can suppress GH secretion, leading to a false-negative result for deficiency. You may drink small sips of plain water to stay hydrated, but avoid any caloric beverages, caffeine, or supplements that could alter the hypothalamic-pituitary axis response.
2. My sample needs to be shipped frozen; what does 'DO NOT THAW' mean for home collection?
Our phlebotomist will centrifuge your serum immediately on-site, then place the separated serum aliquot directly into a validated transport deep-freezer at -20°C, preventing any thaw cycle during transit. Any thermal excursion above -20°C will degrade the labile IGF-1 molecules, and a recollected sample will be mandatory at no extra clinical cost to ensure analytical integrity.
3. How does UAE PDPL protect my health data linked to this growth panel?
All data handling complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring your ICD-10 coded results and clinical data are encrypted, de-identified, and stored exclusively on sovereign Dubai Health Authority cloud servers. Access is strictly permissioned to your referring physician and you, with a full audit trail maintained for every data access request. Additionally, Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields governs the secure digital transmission of your health information.
UAE Regulatory & Data Privacy Adherence
Your data security is our priority. All diagnostic information associated with the Growth Disorder Comprehensive Panel is handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your results are encrypted, stored on secure DHA servers, and accessible only to you and your authorized healthcare provider. DNA Labs UAE maintains strict access controls and audit logs to safeguard your privacy.
Clinical & Logistical Metadata
| Test Name | Growth Disorder Comprehensive Panel |
| Price (AED) | 1800 |
| Turnaround Time | Same-Day (Sample received Mon-Thu before 4 PM) |
| Sample Type / Matrix | Serum |
| Methodology Used | Chemiluminescent Immunoassay (CLIA) |
| ICD-10-CM Code | E34.3, Z13.821 |
| LOINC Code | 41653-9, 14896-8 |
| DHA Facility License & Laboratory Address | DHA License: 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians